188 related articles for article (PubMed ID: 12537586)
21. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
22. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
23. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
Grimmig T; Moench R; Kreckel J; Haack S; Rueckert F; Rehder R; Tripathi S; Ribas C; Chandraker A; Germer CT; Gasser M; Waaga-Gasser AM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941651
[TBL] [Abstract][Full Text] [Related]
24. Growth factors in bladder cancer.
Liebert M
World J Urol; 1995; 13(6):349-55. PubMed ID: 9116754
[TBL] [Abstract][Full Text] [Related]
25. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes.
Krakowski ML; Kritzik MR; Jones EM; Krahl T; Lee J; Arnush M; Gu D; Mroczkowski B; Sarvetnick N
J Endocrinol; 1999 Aug; 162(2):167-75. PubMed ID: 10425454
[TBL] [Abstract][Full Text] [Related]
26. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells.
Wenger C; Ellenrieder V; Alber B; Lacher U; Menke A; Hameister H; Wilda M; Iwamura T; Beger HG; Adler G; Gress TM
Oncogene; 1999 Jan; 18(4):1073-80. PubMed ID: 10023684
[TBL] [Abstract][Full Text] [Related]
27. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
28. Trophic and neurotrophic factors in human pituitary adenomas (Review).
Spoletini M; Taurone S; Tombolini M; Minni A; Altissimi G; Wierzbicki V; Giangaspero F; Parnigotto PP; Artico M; Bardella L; Agostinelli E; Pastore FS
Int J Oncol; 2017 Oct; 51(4):1014-1024. PubMed ID: 28902350
[TBL] [Abstract][Full Text] [Related]
29. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
[TBL] [Abstract][Full Text] [Related]
31. Oligodendrocytes as providers of growth factors.
Du Y; Dreyfus CF
J Neurosci Res; 2002 Jun; 68(6):647-54. PubMed ID: 12111826
[TBL] [Abstract][Full Text] [Related]
32. [Role of biologically active agents in the pathogenesis of proliferative vitreoretinopathy].
Boĭko EV; Roshkius VP
Vestn Oftalmol; 2008; 124(6):51-3. PubMed ID: 19205405
[No Abstract] [Full Text] [Related]
33. Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Rizzino A; Kazakoff P; Ruff E; Kuszynski C; Nebelsick J
Cancer Res; 1988 Aug; 48(15):4266-71. PubMed ID: 3260536
[TBL] [Abstract][Full Text] [Related]
34. [Growth factors in human gastrointestinal carcinomas].
Yasui W; Yoshida K; Tahara E
Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1371-8. PubMed ID: 1651543
[No Abstract] [Full Text] [Related]
35. Changes in growth factor expression in the ageing prostate may disrupt epithelial-stromal homeostasis.
Slater M; Barden JA; Murphy CR
Histochem J; 2000 Jun; 32(6):357-64. PubMed ID: 10943850
[TBL] [Abstract][Full Text] [Related]
36. Growth factors and their receptors in pancreatic cancer.
Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
[TBL] [Abstract][Full Text] [Related]
37. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome.
Tal R; Seifer DB; Arici A
Semin Reprod Med; 2015 May; 33(3):195-207. PubMed ID: 26036901
[TBL] [Abstract][Full Text] [Related]
38. Peptide growth factors in the intestine.
Dignass AU; Sturm A
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):763-70. PubMed ID: 11474304
[TBL] [Abstract][Full Text] [Related]
39. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
[TBL] [Abstract][Full Text] [Related]
40. Growth factors in early hair follicle morphogenesis.
McElwee K; Hoffmann R
Eur J Dermatol; 2000; 10(5):341-50. PubMed ID: 10882941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
